Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $0.43 +0.01 (+2.39%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Ensysce Biosciences Short Interest DataCurrent Short Interest229,800 sharesPrevious Short Interest275,500 sharesChange Vs. Previous Month-16.59%Dollar Volume Sold Short$106,052.70Short Interest Ratio1.7 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares7,585,000 sharesFloat Size7,290,000 sharesShort Percent of Float3.15%Today's Trading Volume93,471 sharesAverage Trading Volume728,438 sharesToday's Volume Vs. Average13% Short Selling Ensysce Biosciences ? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024229,800 shares $106,052.70 -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139,540.75 +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137,696.00 +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111,090.00 +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85,435.80 +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5,679.36 +134.2%0.1%0 $0.59 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/20244,100 shares $2,785.95 -76.6%0.1%0 $0.68 3/31/202417,500 shares $13,828.50 -69.0%0.6%0 $0.79 3/15/202456,500 shares $44,838.40 -34.4%1.9%0 $0.79 2/29/202486,100 shares $80,279.64 +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96 6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83 6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35 5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77 12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288,034.56 -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350,211.75 +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282,783.08 -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365,628.99 +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452,089.04 +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169,136.10 +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131,652.36 +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81,007.02 -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796,730.00 +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469,730.00 +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353,628.00 +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139,752.00 -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402,416.00 +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211,800.00 -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608,478.00 +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347,680.00 -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170,956.00 +18.1%1.4%0 $1.58 11/15/202191,600 shares $196,024.00 -58.3%1.2%0.1 $2.14 10/29/2021219,900 shares $483,780.00 +140.3%2.8%0.2 $2.20 10/15/202191,500 shares $216,855.00 -38.8%1.2%0 $2.37 9/30/2021149,400 shares $452,682.00 +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120,651.00 -20.1%0.4%0 $3.07 8/31/202149,200 shares $155,472.00 +59.7%0.5%0 $3.16 8/13/202130,800 shares $101,024.00 No Change0.3%0 $3.28 ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 229,800 shares of ENSC short. 3.15% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest. What is a good short interest ratio for Ensysce Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENSC shares currently have a short interest ratio of 2.0. Learn More on Ensysce Biosciences's short interest ratio. What is a good short interest percentage for Ensysce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.15% of Ensysce Biosciences' floating shares are currently sold short. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 229,800 shares, a drop of 16.6% from the previous total of 275,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ensysce Biosciences' float size? Ensysce Biosciences currently has issued a total of 7,590,000 shares. Some of Ensysce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ensysce Biosciences currently has a public float of 7,290,000 shares. How does Ensysce Biosciences' short interest compare to its competitors? 3.15% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ensysce Biosciences: Kiora Pharmaceuticals, Inc. (0.67%), Avalo Therapeutics, Inc. (6.64%), Vaxxinity, Inc. (3.61%), Chemomab Therapeutics Ltd. (0.88%), Guardion Health Sciences, Inc. (6.65%), Lumos Pharma, Inc. (6.97%), Monopar Therapeutics Inc. (0.67%), Imunon, Inc. (2.99%), Eterna Therapeutics Inc. (1.84%), Vaccinex, Inc. (1.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Kiora Pharmaceuticals Short Interest Avalo Therapeutics Short Interest Vaxxinity Short Interest Chemomab Therapeutics Short Interest Guardion Health Sciences Short Interest Lumos Pharma Short Interest Monopar Therapeutics Short Interest Imunon Short Interest Eterna Therapeutics Short Interest Vaccinex Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
